178 related articles for article (PubMed ID: 33226726)
1. CD69+ resident memory T cells are associated with graft-versus-host disease in intestinal transplantation.
Weiner J; Svetlicky N; Kang J; Sadat M; Khan K; Duttargi A; Stovroff M; Moturi S; Kara Balla A; Hyang Kwon D; Kallakury B; Hawksworth J; Subramanian S; Yazigi N; Kaufman S; Pasieka HB; Matsumoto CS; Robson SC; Pavletic S; Zasloff M; Fishbein TM; Kroemer A
Am J Transplant; 2021 May; 21(5):1878-1892. PubMed ID: 33226726
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease.
Juchem KW; Sacirbegovic F; Zhang C; Sharpe AH; Russell K; McNiff JM; Demetris AJ; Shlomchik MJ; Shlomchik WD
J Immunol; 2018 Jan; 200(2):834-846. PubMed ID: 29212909
[TBL] [Abstract][Full Text] [Related]
3. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.
Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519
[TBL] [Abstract][Full Text] [Related]
4. Implications of Resident Memory T Cells for Transplantation.
Beura LK; Rosato PC; Masopust D
Am J Transplant; 2017 May; 17(5):1167-1175. PubMed ID: 27804207
[TBL] [Abstract][Full Text] [Related]
5. CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD.
Dutt S; Baker J; Kohrt HE; Kambham N; Sanyal M; Negrin RS; Strober S
Blood; 2011 Mar; 117(11):3230-9. PubMed ID: 21239702
[TBL] [Abstract][Full Text] [Related]
6. Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.
Lu SX; Kappel LW; Charbonneau-Allard AM; Atallah R; Holland AM; Turbide C; Hubbard VM; Rotolo JA; Smith M; Suh D; King C; Rao UK; Yim N; Bautista JL; Jenq RR; Penack O; Na IK; Liu C; Murphy G; Alpdogan O; Blumberg RS; Macian F; Holmes KV; Beauchemin N; van den Brink MR
PLoS One; 2011; 6(7):e21611. PubMed ID: 21760897
[TBL] [Abstract][Full Text] [Related]
7. Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia.
Zheng H; Matte-Martone C; Jain D; McNiff J; Shlomchik WD
J Immunol; 2009 May; 182(10):5938-48. PubMed ID: 19414745
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease.
Khandelwal P; Lane A; Chaturvedi V; Owsley E; Davies SM; Marmer D; Filipovich AH; Jordan MB; Marsh RA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1215-22. PubMed ID: 25881755
[TBL] [Abstract][Full Text] [Related]
9. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
[TBL] [Abstract][Full Text] [Related]
10. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Sairafi D; Stikvoort A; Gertow J; Mattsson J; Uhlin M
J Immunol Res; 2016; 2016():5601204. PubMed ID: 27965986
[No Abstract] [Full Text] [Related]
11. Long-term skin-resident memory T cells proliferate in situ and are involved in human graft-versus-host disease.
Strobl J; Pandey RV; Krausgruber T; Bayer N; Kleissl L; Reininger B; Vieyra-Garcia P; Wolf P; Jentus MM; Mitterbauer M; Wohlfarth P; Rabitsch W; Stingl G; Bock C; Stary G
Sci Transl Med; 2020 Nov; 12(570):. PubMed ID: 33208504
[TBL] [Abstract][Full Text] [Related]
12. T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor.
Jiang H; Fu D; Bidgoli A; Paczesny S
Front Immunol; 2021; 12():761448. PubMed ID: 34675938
[TBL] [Abstract][Full Text] [Related]
13. CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans.
Stanzani M; Martins SL; Saliba RM; St John LS; Bryan S; Couriel D; McMannis J; Champlin RE; Molldrem JJ; Komanduri KV
Blood; 2004 Feb; 103(3):1140-6. PubMed ID: 12907445
[TBL] [Abstract][Full Text] [Related]
14. Immune cell subset counts associated with graft-versus-host disease.
Podgorny PJ; Liu Y; Dharmani-Khan P; Pratt LM; Jamani K; Luider J; Auer-Grzesiak I; Mansoor A; Williamson TS; Ugarte-Torres A; Hoegh-Petersen M; Stewart DA; Daly A; Khan FM; Russell JA; Storek J
Biol Blood Marrow Transplant; 2014 Apr; 20(4):450-62. PubMed ID: 24406506
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
[TBL] [Abstract][Full Text] [Related]
16. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
[TBL] [Abstract][Full Text] [Related]
17. [The impact of donor naive and memory T cell subsets on patient outcome following allogeneic stem cell transplantation: relationship between infused donor CD4+/CCR7+ T cell subsets and acute graft-versus-host disease].
Choufi B; Thiant S; Trauet J; Cliquennois M; Cherrel M; Boulanger F; Coiteux V; Magro L; Labalette M; Yakoub-Agha I
Pathol Biol (Paris); 2014 Jun; 62(3):123-8. PubMed ID: 24906571
[TBL] [Abstract][Full Text] [Related]
18. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.
Zhao K; Zhao D; Huang D; Song X; Chen C; Pan B; Wu Q; Cao J; Yao Y; Zeng L; Xu K
Immunobiology; 2013 Dec; 218(12):1505-13. PubMed ID: 23816304
[TBL] [Abstract][Full Text] [Related]
19. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
Johnson BD; Becker EE; Truitt RL
Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
[TBL] [Abstract][Full Text] [Related]
20. IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation.
Sun K; Hsiao HH; Li M; Ames E; Bouchlaka M; Welniak LA; Hagino T; Jagdeo J; Pai CC; Chen M; Blazar BR; Abedi M; Murphy WJ
J Immunol; 2012 Aug; 189(4):2033-42. PubMed ID: 22778394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
